US PHARMACIST

Scope & Guideline

Empowering Pharmacy Practice for a Healthier Tomorrow

Introduction

Welcome to the US PHARMACIST information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of US PHARMACIST, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0148-4818
PublisherJOBSON PUBLISHING LLC
Support Open AccessNo
CountryUnited States
TypeTrade Journal
Converge1979, from 1990 to 1996, from 2007 to 2024
AbbreviationUS PHARM / US Pharm.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address100 AVE OF THE AMERICAS, NEW YORK, NY 10013-1678

Aims and Scopes

The journal 'US Pharmacist' focuses on advancing the knowledge and practice of pharmacy through a broad range of topics that address current issues, therapeutic advancements, clinical guidelines, and the pharmacist's role in patient care.
  1. Pharmacotherapy and Treatment Guidelines:
    The journal consistently covers pharmacotherapy options and treatment guidelines across various diseases, including chronic conditions, infectious diseases, and mental health disorders, emphasizing evidence-based practices.
  2. Role of Pharmacists in Healthcare:
    A significant focus is placed on the evolving role of pharmacists in patient care, including their involvement in immunizations, managing chronic diseases, and addressing health disparities, showcasing the importance of pharmacists in the healthcare system.
  3. Emerging Therapies and Drug Approvals:
    The journal highlights recent advancements in drug approvals and emerging therapies, particularly for complex conditions such as cancer, diabetes, and infectious diseases, providing pharmacists with the latest information to enhance patient care.
  4. Public Health and Preventive Care:
    Topics related to public health initiatives, preventive care strategies, and health education are prominently featured, reflecting the journal's commitment to improving community health outcomes.
  5. Mental Health and Substance Use Disorders:
    The journal addresses the intersection of mental health and substance use, discussing pharmacological and non-pharmacological interventions, thereby supporting pharmacists in managing these complex issues.
The 'US Pharmacist' journal has shown a dynamic evolution in its focus areas, with several emerging and trending themes reflecting contemporary challenges and advancements in pharmacy practice.
  1. Telehealth and Digital Health Solutions:
    There is a growing emphasis on telehealth and digital health solutions, driven by the COVID-19 pandemic's impact on healthcare delivery, showcasing the importance of pharmacists in virtual care settings.
  2. Pharmacogenomics and Personalized Medicine:
    The trend towards personalized medicine and pharmacogenomics is gaining traction, with increasing discussions on how genetic factors influence drug therapy and patient outcomes, indicating a shift towards precision medicine.
  3. Mental Health Interventions:
    Recent publications highlight a surge in topics related to mental health interventions, reflecting a broader recognition of mental health's importance in overall patient care and the pharmacist's role in managing these conditions.
  4. Health Disparities and Equity:
    Emerging discussions around health disparities and equity emphasize the role of pharmacists in addressing social determinants of health, aligning with national initiatives aimed at reducing healthcare inequities.
  5. Innovations in Chronic Disease Management:
    There is an increasing focus on innovative approaches to managing chronic diseases, particularly through the use of new technologies and therapies, which are crucial for improving patient outcomes.

Declining or Waning

While 'US Pharmacist' has a robust array of topics, some themes appear to be declining in prominence based on recent publications. This may reflect shifting priorities within the field of pharmacy and healthcare.
  1. Traditional Infectious Disease Management:
    There has been a noticeable decline in articles specifically focused on traditional infectious disease management, possibly due to the saturation of content in previous years and a shift towards more innovative and complex therapeutic discussions.
  2. General Nutritional Supplements:
    The frequency of articles discussing general nutritional supplements has decreased, suggesting a possible waning interest as pharmacists increasingly focus on evidence-based pharmacotherapy over supplementation.
  3. Basic Patient Education Topics:
    Basic patient education topics, while still important, are less frequently covered as the journal shifts to more advanced and specialized content that addresses complex pharmaceutical care issues.

Similar Journals

Pharmaceutical Care Espana

Connecting Research and Practice in Pharmacy
Publisher: FUNDACION PHARMACEUTICAL CARE ESPANAISSN: 1139-6202Frequency: 6 issues/year

Pharmaceutical Care España, published by the Fundación Pharmaceutical Care España, is a pivotal open-access journal dedicated to the field of pharmaceutical care, with a commitment to enhancing the practice and understanding of pharmacy in Spain and beyond. Since its establishment, the journal has sought to provide a platform for innovative research, case studies, and reviews that address the evolving landscape of pharmacy and its integral role in health care. With an ISSN of 1139-6202, the journal has gained recognition within the academic community, reflected in its Scopus rankings across various categories, including a rank of #13/21 in Health Professions _ Pharmacy and #142/181 in Pharmacology, Toxicology and Pharmaceutics. Although coverage in Scopus was discontinued in 2017, Pharmaceutical Care España continues to attract global attention through its open-access model, facilitating the dissemination of critical knowledge to researchers, professionals, and students in the pharmaceutical sciences. Emphasizing the importance of collaboration and communication in healthcare, this journal aims to bridge gaps between teori, practice, and public health outcomes, making it a valuable resource for advancing pharmacy care.

Asia-Pacific Journal of Public Health

Shaping public health policy with evidence-based research.
Publisher: SAGE PUBLICATIONS INCISSN: 1010-5395Frequency: 8 issues/year

Asia-Pacific Journal of Public Health, published by SAGE Publications Inc, is a leading platform for disseminating scholarly research in the field of public health. With an impressive scope that spans from the late 1980s to the present, the journal offers a wealth of articles that address critical issues faced by diverse populations in the Asia-Pacific region. Categorized in the Q3 quartile for both Medicine (miscellaneous) and Public Health, Environmental and Occupational Health, it holds a significant position within its field, ranked 310 out of 665 in the Scopus database. Researchers and professionals have access to valuable insights that inform public health policy and practice, making this journal an essential resource for those aiming to enhance health outcomes in the region. While not currently open access, the journal's rigorous peer-review process ensures the integrity and relevance of its content. As the landscape of public health continues to evolve, the Asia-Pacific Journal of Public Health remains a vital resource for advancing knowledge, fostering collaboration, and promoting a healthier society.

JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Exploring the forefront of pharmacology for better health outcomes.
Publisher: ELSEVIERISSN: 1544-3191Frequency: 6 issues/year

The JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, published by Elsevier, serves as a pivotal resource for professionals and researchers in the field of pharmacology and pharmacy. With an impressive 2023 impact factor and classification in the top quartiles (Q1 and Q2) of pharmacology and nursing, this journal is recognized for its high-quality research and contributions that shape contemporary pharmaceutical practices. This journal addresses a broad spectrum of topics within the pharmaceutical sciences, offering insights into the latest advancements in medication management, patient care, and health policy. As a trusted platform for disseminating knowledge, it aims to enhance the professional development of pharmacists and pharmacy practitioners. By maintaining rigorous peer-review standards and a commitment to the dissemination of innovative research, the journal plays a crucial role in advancing the field of pharmacy and improving health outcomes on a global scale.

SAUDI PHARMACEUTICAL JOURNAL

Fostering knowledge sharing in the world of pharmacology.
Publisher: ELSEVIERISSN: 1319-0164Frequency: 8 issues/year

SAUDI PHARMACEUTICAL JOURNAL, published by Elsevier, stands as a pivotal platform for scholarly communication within the realm of pharmaceutical sciences and pharmacology. With a commendable Q2 ranking in both Pharmaceutical Science and Pharmacology for 2023, this journal reflects a strong commitment to advancing scientific understanding and innovation. Open Access since 2009, the journal ensures that cutting-edge research is readily accessible to researchers, professionals, and students around the globe, fostering collaboration and knowledge sharing. Based in the Netherlands, the journal covers a wide scope of topics, contributing to a cumulative understanding of drug development, therapeutic strategies, and pharmaceutical education. With a significant presence in Scopus rankings—#57 in Pharmaceutical Science and #116 in Pharmacology—SAUDI PHARMACEUTICAL JOURNAL is a trusted resource for high-quality research that shapes the future of pharmaceutical sciences.

FARMACIA HOSPITALARIA

Innovative research bridging clinical and pharmaceutical sciences.
Publisher: ELSEVIER SCIENCE INCISSN: 1130-6343Frequency: 6 issues/year

FARMACIA HOSPITALARIA, published by Elsevier Science Inc, is a premier open access journal that has been contributing to the fields of Medicine and Pharmacology since its inception in 1990. Based in the Netherlands, this journal provides a vital platform for the dissemination of high-quality research related to hospital pharmacy practice, medication management, and therapeutic outcomes. With an impressive scope that bridges clinical and pharmaceutical sciences, it positions itself within the 3rd quartile of both Medicine (miscellaneous) and Pharmacology categories, showcasing its relevance and evolving contributions to healthcare discourse. Since adopting an open access model in 2005, FARMACIA HOSPITALARIA has committed to making its research widely available, facilitating knowledge sharing among professionals and academics alike. Researchers and practitioners looking to stay updated with the latest advancements in pharmacy and clinical practices will find this journal an indispensable resource.

CANADIAN JOURNAL OF HOSPITAL PHARMACY

Empowering Pharmacy Practice Through Evidence-Based Research
Publisher: CANADIAN SOC HOSPITAL PHARMACISTSISSN: 0008-4123Frequency: 4 issues/year

Canadian Journal of Hospital Pharmacy, published by the Canadian Society of Hospital Pharmacists, stands as a pivotal resource within the field of pharmacy and medical pharmacology since its inception in 1973. With its ISSN 0008-4123, this peer-reviewed journal aims to advance the knowledge and practice of hospital pharmacy through the dissemination of high-quality research, reviews, and case studies. Although currently not an open-access journal, it boasts a respectable influence in the academic community, reflected in its Q3 quartile rankings in both pharmacology and pharmacy as of 2023. Located in Ottawa, Canada, the journal encourages contributions that emphasize evidence-based practices and innovative solutions to enhance patient care. By fostering a dialogue among pharmacists, researchers, and healthcare professionals, the Canadian Journal of Hospital Pharmacy continues to be an essential platform for addressing contemporary issues and advancements in the hospital pharmacy landscape.

Asian Journal of Pharmaceutical Research and Health Care

Connecting Researchers to Transform Health Care
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2250-1444Frequency: 4 issues/year

Asian Journal of Pharmaceutical Research and Health Care, published by Wolters Kluwer Medknow Publications, serves as a vital platform for disseminating cutting-edge research in the fields of pharmacology, toxicology, and healthcare. With an ISSN of 2250-1444 and an E-ISSN of 2250-1460, this journal aims to provide valuable insights and advancements in pharmaceutical sciences, targeting researchers, practitioners, and students dedicated to improving health outcomes. Although its coverage in Scopus was discontinued in 2016, the journal maintains importance within the academic community by fostering discourse and sharing knowledge on emerging topics. Despite its challenges reflected in the low Scopus ranking within its category, the Asian Journal of Pharmaceutical Research and Health Care remains committed to enhancing access to critical research and publishing high-quality work that bridges the gap between theory and practice in health care. Researchers and professionals engaged in the pharmaceutical field are encouraged to contribute and leverage this journal as a means to advance their work and elevate healthcare standards in Asia and beyond.

Journal of Pharmaceutical Policy and Practice

Enhancing patient care through informed pharmaceutical policies.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Journal of Pharmaceutical Policy and Practice, published by Taylor & Francis Ltd, is a premier open access journal dedicated to advancing the field of pharmaceutical policy and practice. Launched in 2013, this esteemed journal has rapidly become a vital resource for researchers, practitioners, and policymakers alike, offering a critical examination of health policies and their implementation in pharmaceutical contexts. With an impressive impact factor reflecting its significance, it ranks in the Q2 category for Health Policy and Q1 in both Pharmacology, Toxicology and Pharmaceutics and Pharmacy, showcasing its high-quality contributions to the field. Accessible to a global audience since 2014, the journal disseminates innovative research findings that inform best practices, foster policy development, and enhance patient outcomes in the pharmaceutical landscape. Positioned in the UK and with strong Scopus rankings, specifically ranked #3 in Health Professions (Pharmacy), the journal serves as an essential platform for those striving to navigate the ever-evolving intersection of healthcare and pharmaceutical sciences.

Pharmacy Practice-Granada

Empowering pharmacy practice through innovative research.
Publisher: CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICASISSN: 1885-642XFrequency: 4 issues/year

Pharmacy Practice-Granada is an esteemed academic journal dedicated to advancing the field of pharmacy and pharmaceutical sciences. Published by CENTRO INVESTIGACIONES & PUBLICACIONES FARMACEUTICAS, this journal has been a pioneer in Open Access publishing since 2006, allowing researchers worldwide to disseminate their findings without barriers. Operating out of Spain, it provides a platform for innovative research and critical discourse in pharmaceutical practice and education. As of 2023, the journal is ranked in the Q2 category for Pharmaceutical Science and holds a prestigious Q1 ranking in Pharmacy, reflecting its impact and contribution within the academic community. With a strong Scopus ranking, positioned as #6 out of 45 in Health Professions – Pharmacy and a percentile of 87%, the journal serves as a vital resource for practitioners, researchers, and students alike who are committed to enhancing health outcomes through pharmacy. With a commitment to high-quality research, Pharmacy Practice-Granada aims to support knowledge exchange and foster collaborative efforts, ultimately shaping the future of pharmaceutical care.

Pharmacy

Exploring the frontiers of pharmaceutical sciences without barriers.
Publisher: MDPIISSN: Frequency: 6 issues/year

Pharmacy is a premier open-access journal published by MDPI, dedicated to advancing research in the dynamic field of pharmaceutical sciences. Since its inception in 2013, this journal has become a vital platform for disseminating novel findings, reviews, and insights related to drug development, pharmacokinetics, pharmaceutical technology, and clinical applications. With an E-ISSN of 2226-4787, Pharmacy prioritizes accessibility and visibility, allowing researchers, professionals, and students from around the globe to engage with cutting-edge research without barriers. The journal plays a crucial role in shaping pharmaceutical education and practice, fostering innovative ideas and collaborative approaches aimed at improving health outcomes. As part of the MDPI family, Pharmacy is committed to maintaining high-quality standards, ensuring that all published articles undergo rigorous peer review.